Cannabix Technologies Inc. (BLOZF)
USD 0.41
(-5.16%)
USD 0.41
(-5.16%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -2.96 Million CAD | -47.26% |
| 2023 | -2.01 Million CAD | 40.84% |
| 2022 | -3.11 Million CAD | 64.04% |
| 2021 | -9.1 Million CAD | -193.75% |
| 2020 | -6.88 Million CAD | 20.91% |
| 2019 | -3.83 Million CAD | -174.8% |
| 2018 | -1.34 Million CAD | 61.12% |
| 2017 | -3.53 Million CAD | -276.03% |
| 2016 | - CAD | 41.35% |
| 2015 | -1.52 Million CAD | -607.5% |
| 2014 | -239.69 Thousand CAD | -206.19% |
| 2013 | -25.67 Thousand CAD | 64.43% |
| 2012 | -220.07 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -974.36 Thousand CAD | -115.79% |
| 2024 Q1 | -532.99 Thousand CAD | -539.05% |
| 2024 Q2 | -946.68 Thousand CAD | -77.62% |
| 2024 Q3 | -451.54 Thousand CAD | 52.3% |
| 2024 FY | - CAD | -59.35% |
| 2023 Q1 | -548.48 Thousand CAD | 14.47% |
| 2023 FY | - CAD | 40.84% |
| 2023 Q4 | -83.4 Thousand CAD | 88.46% |
| 2023 Q2 | -597.6 Thousand CAD | -8.96% |
| 2023 Q3 | -722.73 Thousand CAD | -20.94% |
| 2022 Q3 | -1.59 Million CAD | -166.99% |
| 2022 Q1 | -537.45 Thousand CAD | 92.45% |
| 2022 FY | - CAD | 64.04% |
| 2022 Q4 | -641.29 Thousand CAD | 59.72% |
| 2022 Q2 | -596.33 Thousand CAD | -10.96% |
| 2021 FY | - CAD | -193.75% |
| 2021 Q3 | -7.17 Million CAD | -1396.88% |
| 2021 Q1 | -1.1 Million CAD | -63.34% |
| 2021 Q2 | -479.59 Thousand CAD | 56.58% |
| 2021 Q4 | -7.12 Million CAD | 0.8% |
| 2020 Q3 | -518.08 Thousand CAD | 63.84% |
| 2020 Q4 | -676.25 Thousand CAD | -30.53% |
| 2020 FY | - CAD | 20.91% |
| 2020 Q1 | -533.07 Thousand CAD | 40.73% |
| 2020 Q2 | -1.43 Million CAD | -168.74% |
| 2019 Q2 | -2.27 Million CAD | -644.29% |
| 2019 FY | - CAD | -174.8% |
| 2019 Q3 | -519.05 Thousand CAD | 77.16% |
| 2019 Q4 | -899.44 Thousand CAD | -73.29% |
| 2019 Q1 | -305.3 Thousand CAD | 36.04% |
| 2018 Q2 | -360.68 Thousand CAD | -21.58% |
| 2018 FY | - CAD | 61.12% |
| 2018 Q3 | -336.65 Thousand CAD | 6.66% |
| 2018 Q1 | -296.67 Thousand CAD | 75.67% |
| 2018 Q4 | -477.32 Thousand CAD | -41.79% |
| 2017 Q4 | -1.21 Million CAD | 18.67% |
| 2017 Q3 | -1.49 Million CAD | -557.64% |
| 2017 Q1 | -796.06 Thousand CAD | -108.74% |
| 2017 Q2 | -227.94 Thousand CAD | 71.37% |
| 2017 FY | - CAD | -276.03% |
| 2016 Q1 | -179.66 Thousand CAD | 72.36% |
| 2016 Q3 | -218.98 Thousand CAD | -8.56% |
| 2016 FY | - CAD | 41.35% |
| 2016 Q4 | -381.35 Thousand CAD | -74.15% |
| 2016 Q2 | -201.71 Thousand CAD | -12.27% |
| 2015 FY | - CAD | -607.5% |
| 2015 Q4 | -649.96 Thousand CAD | -138.06% |
| 2015 Q3 | -273.02 Thousand CAD | -43.67% |
| 2015 Q2 | -190.03 Thousand CAD | 71.17% |
| 2015 Q1 | -659.23 Thousand CAD | -272.25% |
| 2014 Q3 | -107.27 Thousand CAD | -58.31% |
| 2014 Q4 | -177.09 Thousand CAD | -65.08% |
| 2014 Q2 | -67.76 Thousand CAD | -249.06% |
| 2014 Q1 | -19.41 Thousand CAD | 66.14% |
| 2014 FY | - CAD | -206.19% |
| 2013 Q1 | -7965.00 CAD | 0.0% |
| 2013 FY | - CAD | 64.43% |
| 2013 Q4 | -57.33 Thousand CAD | -1141.1% |
| 2013 Q3 | -4620.00 CAD | 44.73% |
| 2013 Q2 | -8359.00 CAD | -4.95% |
| 2012 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -1.16 Million USD | -154.435% |
| SS Innovations International, Inc. | -20.37 Million USD | 85.465% |
| Össur hf. | 137.38 Million USD | 102.156% |
| Össur hf. | 137.38 Million USD | 102.156% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| QHSLab, Inc. | -91.29 Thousand USD | -3144.08% |
| BrainsWay Ltd. | -2.31 Million USD | -28.153% |
| BioElectronics Corporation | -274.29 Thousand USD | -979.74% |
| AVITA Medical, Inc. | -39.56 Million USD | 92.515% |
| Zecotek Photonics Inc. | -3.44 Million USD | 13.962% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| Wellstar International, Inc. | -1.35 Million USD | -118.325% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 153.637% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 130.301% |
| Escalon Medical Corp. | -58.46 Thousand USD | -4965.972% |
| Aurora Spine Corporation | -454.37 Thousand USD | -551.796% |
| NewCardio, Inc. | -9.37 Million USD | 68.424% |
| Avitar, Inc. | -1.66 Million USD | -77.576% |
| Vivos Inc. | -2.79 Million USD | -6.032% |
| Theraclion SA | -2.05 Million USD | -44.414% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -1398.105% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -77.496% |
| Positron Corporation | -1.45 Million USD | -103.947% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -681.623% |
| Nanomix Corporation | -8.13 Million USD | 63.615% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -318.882% |
| Stratec SE | 39.91 Million USD | 107.42% |
| Heart Tronics, Inc. | -14.85 Million USD | 80.066% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -2404.349% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -71.999% |
| Lombard Medical, Inc. | -28.06 Million USD | 89.448% |
| ALR Technologies Inc. | -6.4 Million USD | 53.727% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.148% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 3033.951% |
| VMS Rehab Systems, Inc. | -68.55 USD | -4320276.368% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 77.693% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 5.259% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 67.64% |
| Ingen Technologies, Inc. | -8639.00 USD | -34181.954% |
| United American Healthcare Corporation | -59 Thousand USD | -4919.692% |
| Odyssey Group International, Inc. | -2.13 Million USD | -38.518% |
| IR-Med Inc. | -4.89 Million USD | 39.46% |
| Polarean Imaging plc | -11.19 Million USD | 73.545% |
| ECGI Holdings, Inc. | -2.99 Million USD | 0.964% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -370.709% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -476.162% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 749.392% |
| Urologix, Inc. | -6.34 Million USD | 53.316% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -138.963% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -286.651% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -1229.165% |
| Smith & Nephew plc | 1 Billion USD | 100.295% |
| NIOX Group Plc | 11.07 Million USD | 126.741% |
| Fuse Medical, Inc. | 1.83 Million USD | 261.368% |
| Broncus Holding Corporation | -25.19 Million USD | 88.247% |
| Brain Scientific Inc. | -7.93 Million USD | 62.671% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 68.463% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -15995.75% |